CIM
MEDP icon

Cambria Investment Management’s Medpace MEDP Stock Holding History

Cambria Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-556
Closed -$312K – 696
2025
Q4 		$312K Buy
+556
New +$316K 0.02% 489

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cambria Investment Management's MEDP Position: Q1 2026 in Review

Cambria Investment Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 556 shares — an estimated $312K sold.

Cambria Investment Management first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $312K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Cambria Investment Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Cambria Investment Management sold 556 Medpace shares in Q1 2026, an estimated $312K.
  • Cambria Investment Management first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
  • Cambria Investment Management's Medpace position peaked at $312K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.